Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...

Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about ...

A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Trials of a new drug for obesity and type 2 diabetes have seen patients lose 15pc of their body weight and return their blood ...

An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...